# Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-sparsentan-versus-irbesartan-in-focal-segmental/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ahmed A. Abo Elnaga,Mohamed A. Alsaied,Abdelrahman M. Elettreby,Alaa Ramadan,Mohamed Abouzid,Raghda Shetta,Yazan A. Al‐Ajlouni |
| Citations | 3 |
| DOI | 10.1186/s12882-024-03713-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1186/s12882-024-03713-9.pdf |
| OpenAlex ID | https://openalex.org/W4402926609 |
| PMID | 39333921 |
| Type | review |
| Year | 2024 |

## Paper authors

- [Mohamed A. Alsaied](https://scholariq.org/researchers/mohamed-a-alsaied/)
- [Abdelrahman M. Elettreby](https://scholariq.org/researchers/abdelrahman-m-elettreby/)

## Paper journal

- [BMC Nephrology](https://scholariq.org/journals/bmc-nephrology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Proteoglycans and glycosaminoglycans research](https://scholariq.org/topics/proteoglycans-and-glycosaminoglycans-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.